Mental health studies with practical context.

A Phase 3, Randomised, Double-blind, Multicentre, Parallel-group, Placebo- and Active-reference, Dose-optimisation Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

France, United Kingdom, Austria, + 7 others

Sponsor

Shire Pharmaceutical Development Ltd

A phase three study to study the safety and efficacy of three doses of lurasidone hydrochloride (HCl) in acutely psychotic people with schizophrenia

This study isn't currently recruiting.

Countries

France, United States, United Kingdom, + 5 others

Sponsor

Dainippon Sumitomo Pharma America Inc. (USA)

A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects with Schizophrenia

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

France, United Kingdom, Estonia, + 7 others

Sponsor

Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 3 Doses of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

France, United Kingdom, Germany, + 4 others

Sponsor

Takeda Global Research & Development Centre (Europe) Ltd.

Acting by peer for tobacco prevention in young people

This study isn't currently recruiting.

Countries

France

Sponsor

French National Cancer Institute (Institut National du Cancer)

AMIloride for the treatment of Nephrogenic Diabetes insipidus for patients with Bipolarity treated with lithium: a randomized controlled trial

This study isn't currently recruiting.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Countries

France

Sponsor

Assistance Publique – Hôpitaux de Paris (AP-HP)

An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)

This study isn't currently recruiting.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Countries

France, Belgium, Austria, + 18 others

Sponsor

Boehringer Ingelheim

Long-term safety of aticaprant added to antidepressants in adults with depression

This study isn't currently recruiting.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Countries

France, Belgium, Bulgaria, + 8 others

Sponsor

Janssen-Cilag International NV

Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.

This study isn't currently recruiting.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Countries

France

Sponsor

Centre Hospitalier Le Vinatier

Child resilience in Afghanistan study

This study isn't currently recruiting.

Countries

France, Afghanistan

Sponsor

Washington University in St. Louis

Contribution of FAMily THERApy to treat people with Eating disorders (apport de la therapie familiale au traitement des patientes anorexiques mentales)

This study isn't currently recruiting.

Countries

France

Sponsor

Public Assistance Hospitals of Paris (France)

Effects of a prenatal program group led to parental couples to prevent postpartum depression in women of middle and lower classes living in northern Catalonia and Southern France [Effetsd’unprogrammeprénatal de groupeadresséauxcouplesparentauxpourprévenir la dépressionpostnatale des femmes de clases moyenne et défavoriséehabitant en Catalogne Nord et en France Sud]

This study isn't currently recruiting.

Countries

France, Spain

Sponsor

ADERMNCN (Association for better childbirth in Northern Catalonia) (Spain)